PCSK9 and Hypercholesterolemia: To circumvent genetic mouse models of atherosclerosis, we used a single intravenous injection of a well-characterized gain-of-function (D377Y) mouse PCSK9-AAV followed by WD feeding to induce rapid hypercholesterolemia to drive atherogenesis for 12 weeks (supplemental Fig. S2) (23).